L J BIO USA, Inc. is a global leading company specializing in protein therapeutics for neurodegenerative diseases. With their innovative Dual Action Therapy (DAT) platform, they aim to develop effective treatments for neurological disorders such as Alzheimer's and Parkinson's. Headquartered in Seoul, South Korea, L J BIO USA also operates a research institute and GMP facility in Maryland, USA.
Committed to advancing the field of protein therapeutics, L J BIO USA is dedicated to finding solutions for neurodegenerative diseases through their cutting-edge technology and extensive pipeline. Their mission is to improve the lives of individuals affected by these disorders, offering hope for a brighter future.
Generated from the website